000 01291 a2200337 4500
005 20250515084302.0
264 0 _c20071003
008 200710s 0 0 eng d
022 _a1527-9995
024 7 _a10.1016/j.urology.2007.03.052
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhang, Zhengwang
245 0 0 _aEnhanced therapeutic effect on androgen-independent prostate cancer by depsipeptide (FK228), a histone deacetylase inhibitor, in combination with docetaxel.
_h[electronic resource]
260 _bUrology
_cAug 2007
300 _a396-401 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aDepsipeptides
_xadministration & dosage
650 0 4 _aDocetaxel
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aTaxoids
_xadministration & dosage
650 0 4 _aTumor Cells, Cultured
700 1 _aStanfield, Jennifer
700 1 _aFrenkel, Eugene
700 1 _aKabbani, Wareef
700 1 _aHsieh, Jer-Tsong
773 0 _tUrology
_gvol. 70
_gno. 2
_gp. 396-401
856 4 0 _uhttps://doi.org/10.1016/j.urology.2007.03.052
_zAvailable from publisher's website
999 _c17354742
_d17354742